EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin‐Mediated Regulation of ENO1

Na Sun, Yong-Bing Wang, Jing Huang, Run-Wei Deng, Hui-Yu He, Lei Gao, Xuan Gao, You-Li Fan, Yan Cong, Yao-Lei Guo, Yi-Qiang Chen, Gui-Jia Wang und 4 weitere

Advanced Science · 2025-09 · 12 (35)

DOI: 10.1002/advs.202500096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.06.2025. Verfasst von Na Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. Hauptthemen laut MEDLINE: Vascular Remodeling, Phosphopyruvate Hydratase, Fibronectins, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Heilongjiang Graduate Excellence Funding Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary vascular remodeling, which current therapeutic targets fail to alleviate disease severity, plays a key role in pulmonary arterial hypertension (PAH). Irisin is identified as a protective factor involved in regulating inflammation and oxidative stress, but its role in PAH remains unknown. To investigate, plasma irisin levels and its local pulmonary artery expression are measured in patients with PAH and mouse models. Irisin expression is significantly decreased in patients with PAH and PAH mouse models. Furthermore, overexpression and exogenous injection of irisin effectively alleviate hemodynamic and right‐heart function in PAH mouse models, meanwhile, it also reverses proliferation and cell cycle progression of pulmonary artery smooth muscle cells (PASMCs). To illustrate the mechanism of irisin exerts on PAH, Enolase 1 is identified as a key irisin‐interacting protein. Irisin suppresses proliferation of PDGF‐induced PASMCs by promoting ubiquitination status of Enolase 1 via E3 ligase of down regulated protein 4 in neural precursor cell development. Co‐immunoprecipitation and molecular docking analyses verifies the interaction and binding sites between irisin and its interactive proteins. Overall, these findings suggest that, irisin is a novel protective factor downregulated in PAH. By ubiquitination, irisin promotes Enolase 1 degradation and suppresses cell proliferation and pulmonary vascular remodeling in PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular RemodelingPhosphopyruvate HydrataseFibronectinsPulmonary Arterial HypertensionDNA-Binding ProteinsUbiquitinAnimalsMiceHumansDisease Models, AnimalMalePulmonary ArteryMyocytes, Smooth MuscleCell ProliferationMice, Inbred C57BLBiomarkers, TumorTumor Suppressor Proteins

Stichwörter der Autor:innen

enolase 1irisinpulmonary arterial hypertensionpulmonary artery smooth muscle cellsubiquitination

Substanzen

Phosphopyruvate HydrataseFibronectinsDNA-Binding ProteinsENO1 protein, humanUbiquitinFNDC5 protein, mouseFNDC5 protein, humanBiomarkers, TumorTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
  • Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, 150086, China.
  • State Key Laboratory of Frigid Zone Cardiovascular Disease (SKLFCD), Harbin Medical University, 246 Xuefu Road, Harbin, 150086, China.
  • Department of Cardiology, First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
  • Cardiovascular Imaging Center, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.

ORCID-Profile: Bing-Xiang Wu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Heilongjiang Graduate Excellence Funding Program

Zitieren

APA

Sun, N., Wang, Y. B., Huang, J., Deng, R. W., He, H. Y., Gao, L., Gao, X., Fan, Y. L., Cong, Y., Guo, Y. L., Chen, Y. Q., Wang, G. J., Fang, S. H., Gu, X., Yu, B., & Wu, B. X. (2025). Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin‐Mediated Regulation of ENO1. Advanced Science, 12(35). https://doi.org/10.1002/advs.202500096

Vancouver

Sun N, Wang YB, Huang J, Deng RW, He HY, Gao L, et al. Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin‐Mediated Regulation of ENO1. Advanced Science. 2025;12(35). doi:10.1002/advs.202500096

BibTeX
@article{Sun2025,
  author = {Sun, Na and Wang, Yong-Bing and Huang, Jing and Deng, Run-Wei and He, Hui-Yu and Gao, Lei and Gao, Xuan and Fan, You-Li and Cong, Yan and Guo, Yao-Lei and Chen, Yi-Qiang and Wang, Gui-Jia and Fang, Shao-Hong and Gu, Xia and Yu, Bo and Wu, Bing-Xiang},
  title = {Irisin Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension via Ubiquitin‐Mediated Regulation of ENO1},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {35},
  doi = {10.1002/advs.202500096}
}
Kostenlos starten →